Isis Pharmaceuticals, Inc. Form 10K - page 114

Outstanding EquityAwards At December 31, 2014
OptionAwards
StockAwards
Name
Grant
Date
Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable
(1)
Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable
Option
Exercise
Price ($)
Option
Expiration
Date
Number of
Shares or
Units of
Stock that
Have Not
Vested
(2)
Market
Value of
Shares or
Units of
Stock that
Have Not
Vested
(3)
($)
Stanley T. Crooke. . . .
1/4/2010 109,163
— $ 11.27
1/3/2017
1/3/2011 119,552
2,544
$ 10.29
1/2/2018
1/3/2012
78,169
29,034
$ 7.25
1/2/2019
1/30/2013
63,815
69,365
$ 14.69 1/29/2020
1/2/2014
— 187,500
$ 39.87
1/1/2021
1/15/2012
— 5,954 $ 367,600
1/30/2013
— 16,642 $1,027,477
1/15/2014
— 31,250 $1,929,375
Elizabeth L. Hougen. .
1/2/2009
12,657
— $ 14.47
1/1/2016
1/4/2010
20,000
— $ 11.27
1/3/2017
1/3/2011
21,541
459
$ 10.29
1/2/2018
1/3/2012
14,218
5,282
$ 7.25
1/2/2019
1/2/2013
7,522
8,178
$ 10.82
1/1/2020
1/2/2013
3,593
3,907
$ 10.82
1/1/2020
1/2/2014
— 45,000
$ 39.87
1/1/2021
1/15/2012
— 1,082 $ 66,803
1/15/2013
— 937 $ 57,850
1/15/2013
— 1,961 $ 121,072
1/15/2014
— 1,082 $ 66,803
B. Lynne Parshall. . . .
1/3/2011
6,074
1,519
$ 10.29
1/2/2018
1/3/2012
5,146
16,724
$ 7.25
1/2/2019
1/30/2013
27,332
32,438
$ 14.69 1/29/2020
1/2/2014
0
82,500
$ 39.87
1/2/2021
1/15/2012
— 3,430 $ 211,768
1/30/2013
— 7,785 $ 480,646
1/30/2014
— 13,750 $ 848,925
Brett P. Monia . . . . . .
1/3/2011
7,129
471
$ 10.29
1/2/2018
1/1/2012
5,468
2,032
$ 7.21 12/31/2018
1/3/2012
3,849
5,144
$ 7.25
1/2/2019
1/30/2013
16,291
17,709
$ 14.69 1/29/2020
1/2/2014
0
45,000
$ 39.87
1/1/2021
1/15/2012
— 1,054 $ 65,074
1/15/2012
— 416 $ 25,684
1/30/2013
— 4,245 $ 262,086
1/15/2014
— 7,500 $ 463,050
Richard S. Geary . . . .
1/4/2010
80
— $ 11.27
1/3/2017
1/3/2011
7,729
697
$ 10.29
1/2/2018
1/3/2012
6,470
7,565
$ 7.25
1/2/2019
1/30/2013
7,771
17,469
$ 14.69 1/29/2020
1/2/2014
0
45,000
$ 39.87
1/1/2021
1/15/2012
— 1,551 $ 95,759
1/30/2013
— 4,192 $ 258,814
1/15/2014
— 7,500 $ 463,050
(1) The options have a term of seven years and vest at the rate of 25% for the first year and then at the rate of 2.08%per month for 36
months thereafter during the optionee’s employment.
(2) The RSUs were granted out of our 2011 Equity Incentive Plan. The RSUs vest at the rate of 25%per year over four years.
(3) Market value of stock awards was determined by multiplying the number of unvested shares by $61.74, which was the closing market
price of our common stock on the Nasdaq Global Select Market on December 31, 2014, the last trading day of fiscal 2014.
114
I...,104,105,106,107,108,109,110,111,112,113 115,116,117,118,119,120,121,122,123,124,...186
Powered by FlippingBook